Sort
21,281 grants matching “influenza”
Molecular mechanisms for antiviral signaling and regulation by MDA5 and TRIM65
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2023 · AI
Molecular mechanisms for antiviral signaling and regulation by MDA5 and TRIM65
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2020 · AI
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-I
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2016 · AI
Sortase-mediated protein engineering for the study of host-pathogen interactions
$442,500Hidde L Ploegh · Boston Children'S Hospital · R01 · FY2017 · AI
Structural and functional analyses of the RIG-I filament in innate immunity
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2016 · AI
Sortase-mediated protein engineering for the study of host-pathogen interactions
$442,500Hidde L Ploegh · Boston Children'S Hospital · R01 · FY2019 · AI
Electron Spin Relaxation in Model Membranes
$442,462Jack H Freed · Cornell University · R01 · FY2016 · EB
Vaccine and Treatment Evaluation Unit: Consultation and Testing of Cytokine Levels and Cell Activation in Clinical Samples
$442,431Marcelo Sztein · University Of Maryland Baltimore · N01 · FY2019 · AI
The effect of human pre-exposure history on antigenic drift of influenza viruses
$442,406Scott Eric Hensley · Wistar Institute · R01 · FY2015 · AI
SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES
$442,400Michael Ward · World Health Organization · U01 · FY2014 · FD
Structural and functional analyses of the RIG-I filament in innate immunity
$442,292Sun Hur · Boston Children'S Hospital · R01 · FY2015 · AI
Modeling Core
$442,277Sourav Bandyopadhyay · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
Porcine Respiratory Coronavirus as a SARS Model
$442,065Linda J. Saif · Ohio State University · R01 · FY2007 · AI
First Clinical Trial of an Anti-Sickling Botanical Drug for Sickle Cell Dise
$442,059Robert Swift · Invenux, Llc · R43 · FY2013 · HL
The basis of Influenza A virus strain-dependent reassortment potential
$442,004Samuel L Diaz · University Of California At Davis · R01 · FY2025 · AI
IMPACT OF CMV UPON T-CELL AGING AND IMMUNE DEFENSE
$441,978Janko Nikolich-Zugich · University Of Arizona · R01 · FY2014 · AG
HUMAN ANTIBODY REPERTOIRE TO H INFLUENZAE B
$441,961Children'S Hospital &Res Ctr At Oakland · R37 · FY2002 · AI
Antibody and gut bacteria in obesity and T2D
$441,892Li Wen · Yale University · R01 · FY2022 · DK
Antibody and gut bacteria in obesity and T2D
$441,892Li Wen · Yale University · R01 · FY2023 · DK
Functional Study of Native and Synthetic Nuclei
$441,835Douglass J Forbes · University Of California, San Diego · R01 · FY2006 · GM
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-I
$441,458Sun Hur · Boston Children'S Hospital · R01 · FY2015 · AI
Validity of Self-Reported Adult Vaccination Status
$441,340Sharon L Rolnick · Healthpartners Institute · U01 · FY2009 · IP
IL-6: an innate immune regulator for the plasticity of Tfh cells
$441,315Mercedes R. Rincon · University Of Vermont & St Agric College · R56 · FY2012 · AI
Influenza Vaccine Delivery to Adolescents: two multicomponent interventions
$441,288James M. Hughes · Emory University · R18 · FY2008 · IP
Immune control mechanisms of TB latency in the setting of HIV co-infection
$441,250Anne Goldfeld · Boston Children'S Hospital · R56 · FY2015 · AI